Zeke Capital Advisors, LLC Sage Therapeutics, Inc. Transaction History

Zeke Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$60.18 - $154.77 $183,007 - $470,655	-3,041 Closed	0 $0
Q3 2019 Oct 18, 2019	BUY	$140.29 - $189.96 $107,883 - $146,079	769 Added 33.85%	3,041 $427,000
Q2 2018 Jul 24, 2018	BUY	$140.36 - $175.76 $34,949 - $43,764	249 Added 12.31%	2,272 $356,000
Q1 2018 May 03, 2018	BUY	$152.15 - $192.33 $11,259 - $14,232	74 Added 3.8%	2,023 $326,000
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $118,343 - $326,145	1,949	1,949 $321,000

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $631M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.